Close

This is a StreetInsider.com Premium Only Page

Please sign-up to enjoy all the benefits of StreetInsider.com Premium or log-in if you're already a member.

Send to a Friend Font Size: Increase Decrease

Back to ATXI Stock Lookup

(ATXI) – PRNewswire

Mar 10, 2023 06:00 AM AnnJi Pharmaceutical Announced A Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Treatment Of Kennedy's Disease

Back to ATXI Stock Lookup